Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking ...

Professor Peter Johnson, NHS England’s National Clinical Director for Cancer, said: “This is one of the most hopeful advances in decades for people with bladder cancer who will now be offered a ...

In summary, flashbacks that reproduce components of the psychedelic drug experiences after the administration of therapeutic doses are a relatively common phenomenon in clinical trials. Overall, the ...

Tel Aviv University announced on Wednesday that the surgery will take place in Israel, marking a historic milestone in ...

B ristol Myers Squibb and SystImmune have announced breakthrough therapy designation from the US Food and Drug Administration ...

Trump administration accelerates psychedelic therapy timeline while Texas invests $50 million in breakthrough addiction ...

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ifinatamab deruxtecan (I-DXd) for the treatment of adults with extensive-stage small cell lung cancer (ES-SCLC ...

The FDA has granted Breakthrough Therapy designation to ifinatamab deruxtecan for the treatment of extensive-stage small cell lung cancer in pretreated patients.

FDA approved zopapogene imadenovec, the first therapy for recurrent respiratory papillomatosis, providing an option beyond ...

The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung ...

Earlier this month, we learned 22-year-old Daniel Cressy would become the first person in Louisiana to receive a gene therapy ...

A new study from Moffitt Cancer Center may offer a breakthrough for patients with advanced melanoma who don't respond to ...